abstract |
The present invention provides novel purinones and purines useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the genera formulae I and II wherein R 1 , R 2 , R 3 , R 4 , R 9 , Q, A and y are as defined in the specification. |